Long-Term, Open-Label Extension Study to Evaluate the Safety and Tolerability of NBI-827104 in Pediatric Subjects with Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep

Administered By

Awarded By

Contributors

Start/End

  • May 20, 2022 - August 5, 2024